Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group

Marine Sroussi; Reza Elaidi; Aude Fléchon; Marianne Lorcet; Delphine Borchiellini; Magalie P. Tardy; Gwenaelle Gravis; Mathilde Guérin; Brigitte Laguerre; Florian Estrade; Rémi Delva; Phillipe Barthélémy; Yohann Loriot; Pernelle Lavaud; Thierry Lebret; Yann Neuzillet; Nicolas Penel; Nadine Houede; Damien Pouessel; Benoit Rousseau; Elodie Mussat; Marine Gross-Goupil; Stéphane Culine; Hélène Gauthier; Aurélien Gobert; Morgan Roupret; Olivier Huillard; Sophie Tartas; Camélia Radulescu; Yves Allory; Stéphane Oudard

doi:10.1016/j.clgc.2019.11.014

Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group

Marine Sroussi, Reza Elaidi, Aude Fléchon, Marianne Lorcet, Delphine Borchiellini, Magalie P. Tardy, Gwenaelle Gravis, Mathilde Guérin, Brigitte Laguerre, Florian Estrade, Rémi Delva, Phillipe Barthélémy, Yohann Loriot, Pernelle Lavaud, Thierry Lebret, Yann Neuzillet, Nicolas Penel, Nadine Houede, Damien Pouessel, Benoit RousseauElodie Mussat, Marine Gross-Goupil, Stéphane Culine, Hélène Gauthier, Aurélien Gobert, Morgan Roupret, Olivier Huillard, Sophie Tartas, Camélia Radulescu, Yves Allory, Stéphane Oudard

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

14 Citations (Scopus)

Résumé

Neuroendocrine carcinoma of the urinary bladder (NCUB) is a rare and heterogeneous disease, with scarce reported data available. The present retrospective study included 236 patients treated for NCUB. The median overall survival was 36 months for stage I/II, 26 months for stage IIIA, 16 months for stage IIIB, and 13 months for stage IVA/IVB. Disease-free survival was associated with overall survival.

langue originale	Anglais
Pages (de - à)	295-303.e3
journal	Clinical Genitourinary Cancer
Volume	18
Numéro de publication	4
Les DOIs	https://doi.org/10.1016/j.clgc.2019.11.014
état	Publié - 1 août 2020

Accès au document

10.1016/j.clgc.2019.11.014

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Sroussi, M., Elaidi, R., Fléchon, A., Lorcet, M., Borchiellini, D., Tardy, M. P., Gravis, G., Guérin, M., Laguerre, B., Estrade, F., Delva, R., Barthélémy, P., Loriot, Y., Lavaud, P., Lebret, T., Neuzillet, Y., Penel, N., Houede, N., Pouessel, D., ... Oudard, S. (2020). Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group. Clinical Genitourinary Cancer, 18(4), 295-303.e3. https://doi.org/10.1016/j.clgc.2019.11.014

@article{518a3f3264b146488bf19b5a0b6fa0d4,

title = "Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group",

abstract = "Neuroendocrine carcinoma of the urinary bladder (NCUB) is a rare and heterogeneous disease, with scarce reported data available. The present retrospective study included 236 patients treated for NCUB. The median overall survival was 36 months for stage I/II, 26 months for stage IIIA, 16 months for stage IIIB, and 13 months for stage IVA/IVB. Disease-free survival was associated with overall survival.",

keywords = "Chemotherapy, French GETUG consortium, Heterogeneity, Outcomes, Small cell bladder cancer",

author = "Marine Sroussi and Reza Elaidi and Aude Fl{\'e}chon and Marianne Lorcet and Delphine Borchiellini and Tardy, {Magalie P.} and Gwenaelle Gravis and Mathilde Gu{\'e}rin and Brigitte Laguerre and Florian Estrade and R{\'e}mi Delva and Phillipe Barth{\'e}l{\'e}my and Yohann Loriot and Pernelle Lavaud and Thierry Lebret and Yann Neuzillet and Nicolas Penel and Nadine Houede and Damien Pouessel and Benoit Rousseau and Elodie Mussat and Marine Gross-Goupil and St{\'e}phane Culine and H{\'e}l{\`e}ne Gauthier and Aur{\'e}lien Gobert and Morgan Roupret and Olivier Huillard and Sophie Tartas and Cam{\'e}lia Radulescu and Yves Allory and St{\'e}phane Oudard",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2020",

month = aug,

day = "1",

doi = "10.1016/j.clgc.2019.11.014",

language = "English",

volume = "18",

pages = "295--303.e3",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

number = "4",

}

Sroussi, M, Elaidi, R, Fléchon, A, Lorcet, M, Borchiellini, D, Tardy, MP, Gravis, G, Guérin, M, Laguerre, B, Estrade, F, Delva, R, Barthélémy, P, Loriot, Y, Lavaud, P, Lebret, T, Neuzillet, Y, Penel, N, Houede, N, Pouessel, D, Rousseau, B, Mussat, E, Gross-Goupil, M, Culine, S, Gauthier, H, Gobert, A, Roupret, M, Huillard, O, Tartas, S, Radulescu, C, Allory, Y & Oudard, S 2020, 'Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor Group', Clinical Genitourinary Cancer, VOL. 18, Numéro 4, p. 295-303.e3. https://doi.org/10.1016/j.clgc.2019.11.014

TY - JOUR

T1 - Neuroendocrine Carcinoma of the Urinary Bladder

T2 - A Large, Retrospective Study From the French Genito-Urinary Tumor Group

AU - Sroussi, Marine

AU - Elaidi, Reza

AU - Fléchon, Aude

AU - Lorcet, Marianne

AU - Borchiellini, Delphine

AU - Tardy, Magalie P.

AU - Gravis, Gwenaelle

AU - Guérin, Mathilde

AU - Laguerre, Brigitte

AU - Estrade, Florian

AU - Delva, Rémi

AU - Barthélémy, Phillipe

AU - Loriot, Yohann

AU - Lavaud, Pernelle

AU - Lebret, Thierry

AU - Neuzillet, Yann

AU - Penel, Nicolas

AU - Houede, Nadine

AU - Pouessel, Damien

AU - Rousseau, Benoit

AU - Mussat, Elodie

AU - Gross-Goupil, Marine

AU - Culine, Stéphane

AU - Gauthier, Hélène

AU - Gobert, Aurélien

AU - Roupret, Morgan

AU - Huillard, Olivier

AU - Tartas, Sophie

AU - Radulescu, Camélia

AU - Allory, Yves

AU - Oudard, Stéphane

PY - 2020/8/1

Y1 - 2020/8/1

N2 - Neuroendocrine carcinoma of the urinary bladder (NCUB) is a rare and heterogeneous disease, with scarce reported data available. The present retrospective study included 236 patients treated for NCUB. The median overall survival was 36 months for stage I/II, 26 months for stage IIIA, 16 months for stage IIIB, and 13 months for stage IVA/IVB. Disease-free survival was associated with overall survival.

AB - Neuroendocrine carcinoma of the urinary bladder (NCUB) is a rare and heterogeneous disease, with scarce reported data available. The present retrospective study included 236 patients treated for NCUB. The median overall survival was 36 months for stage I/II, 26 months for stage IIIA, 16 months for stage IIIB, and 13 months for stage IVA/IVB. Disease-free survival was associated with overall survival.

KW - Chemotherapy

KW - French GETUG consortium

KW - Heterogeneity

KW - Outcomes

KW - Small cell bladder cancer

UR - http://www.scopus.com/inward/record.url?scp=85076972799&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2019.11.014

DO - 10.1016/j.clgc.2019.11.014

M3 - Article

C2 - 31882335

AN - SCOPUS:85076972799

SN - 1558-7673

VL - 18

SP - 295-303.e3

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 4

ER -